📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

Long-acting injectable atovaquone nanomedicines for malaria prophylaxis. (2018)

First Author: Bakshi RP

Attributed to: Non-Attrition HAART nanoparticle therapies for HIV/AIDS Drug Delivery funded by EPSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41467-017-02603-z

PubMed Identifier: 29358624

Publication URI: http://europepmc.org/abstract/MED/29358624

Type: Journal Article/Review

Volume: 9

Parent Publication: Nature communications

Issue: 1

ISSN: 2041-1723